Search
De Novo Triacylglycerol Biosynthesis TG(i-24:0/21:0/20:0)
smpdb.ca/view/SMP0042749MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(i-24:0/21:0/22:0)
smpdb.ca/view/SMP0042751MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/10:0)
smpdb.ca/view/SMP0042769MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/14:0)
smpdb.ca/view/SMP0042772MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(i-24:0/22:0/16:0)
smpdb.ca/view/SMP0042774MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
De Novo Triacylglycerol Biosynthesis TG(i-24:0/8:0/20:0)
smpdb.ca/view/SMP0042807MetabolicTriglycerides are the main constituents of body fat in humans and other animals, as well as vegetable fat. … (Wikipedia) De novo biosynthesis of triglycerides is also known as the phosphatidic acid pathway, and it is mainly associated with the liver and adipose tissue.
Diltiazem Calcium Channel Cardiac Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0126292Drug action, and rest-related cramps in the lower extremities. … Some side effects of using diltiazem may include dizziness, flushing, headache, and weakness.
Enzymes: Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferaseMersalyl
go.drugbank.com/drugs/DB09338ExperimentalMersalyl is the sodium salt form of mersalyl acid, a mercurial diuretic. It is an outdated drug, and its approval has been discontinued by the FDA. … The sodium salt of a mercury-containing derivative of salicylamide, was formerly used (often in combination with theophylline) to treat edema, due to its powerful diuretic properties [L1577].
Simeprevir
go.drugbank.com/drugs/DB06290ApprovedWithdrawnAccording to 2017 American Association for the Study of Liver Diseases (AASLD) and 2015 consensus guidelines from the Canadian Association for the Study of the Liver (CASL), simeprevir can be used as first-line … Simeprevir is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated in patient's with HCV genotype 1 for the treatment of chronic hepatitis C virus (HCV) infection.
Categories: Cytochrome P-450 Substrates, P-glycoprotein inhibitorsCoVac-1
go.drugbank.com/drugs/DB16429InvestigationalSponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588]. … is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC))[L30428] and aims to induce broad T-cell